Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea flag South Korea · Delayed Price · Currency is KRW
27,050
-400 (-1.46%)
At close: Aug 13, 2026

Aimed Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
1,749,3553,695,395---
Market Cap Growth
-----
Enterprise Value
1,658,2633,612,198---
Last Close Price
27050.0057600.00---
PE Ratio
45.32735.76---
PS Ratio
26.1978.16---
PB Ratio
8.5619.19---
P/TBV Ratio
8.6219.35---
P/FCF Ratio
181.97211.09---
P/OCF Ratio
162.32206.91---
EV/Sales Ratio
30.6076.40---
EV/EBITDA Ratio
85.38163.07---
EV/EBIT Ratio
92.43173.93---
EV/FCF Ratio
172.49206.34---
Debt / Equity Ratio
0.010.010.010.050.11
Debt / EBITDA Ratio
0.060.050.40--
Debt / FCF Ratio
0.160.07---
Net Debt / Equity Ratio
-0.45-0.88-0.78-0.98-0.53
Net Debt / EBITDA Ratio
-3.53-7.66-33.233.211.04
Net Debt / FCF Ratio
-9.48-9.696.884.991.15
Asset Turnover
0.440.380.340.01-
Quick Ratio
16.6331.1716.914.246.99
Current Ratio
17.3331.4317.024.257.13
Return on Equity (ROE)
25.93%4.23%-10.62%-66.75%-
Return on Assets (ROA)
9.85%10.55%-0.73%-24.04%-
Return on Capital Employed (ROCE)
11.80%10.70%-0.90%-35.60%-55.90%
Earnings Yield
2.21%0.14%---
FCF Yield
0.55%0.47%---
Buyback Yield / Dilution
-83.25%-39.67%-4.02%-2.16%-